Cost-effectiveness of the interventions under different modelling scenarios
| Cost-effectiveness ratio (A$/DALY) | ||||
| Including government/food industry costs | + Patient time and travel costs | + Costs of unrelated health care in added years of life | + Lag in risk reversal | |
| Discounted | ||||
| Dietary advice (>140 mm Hg) | 160 000 (99 000 to 280 000)* | 240 000 (160 000 to 400 000) | 250 000 (170 000 to 410 000) | 420 000 (280 000 to 690 000) |
| Dietary advice (>115 mm Hg) | 260 000 (170 000 to 440 000)* | 380 000 (260 000 to 630 000) | 390 000 (270 000 to 640 000) | 670 000 (450 000 to 1 100 000) |
| Tick programme | Dominant (dominant to dominant)* | Dominant (dominant to dominant) | Dominant (dominant to dominant) | Dominant (dominant to dominant) |
| Mandatory limits | Dominant (dominant to dominant)* | Dominant (dominant to dominant) | Dominant (dominant to dominant) | Dominant (dominant to dominant) |
| Undiscounted | ||||
| Dietary advice (>140 mm Hg) | 100 000 (64 000 to 180 000) | 150 000 (100 000 to 270 000) | 160 000 (110 000 to 270 000) | 280 000 (190 000 to 460 000) |
| Dietary advice (>115 mm Hg) | 160 000 (100 000 to 270 000) | 230 000 (160 000 to 390 000) | 240 000 (170 000 to 400 000) | 410 000 (280 000 to 670 000) |
| Tick programme | Dominant (dominant to dominant) | Dominant (dominant to dominant) | Dominant (dominant to dominant) | Dominant (dominant to dominant) |
| Mandatory limits | Dominant (dominant to dominant) | Dominant (dominant to dominant) | Dominant (dominant to dominant) | Dominant (dominant to dominant) |
↵* Base case scenario.
Values are median and 95% uncertainty interval, rounded to two significant figures.
Cost-effectiveness ratios are in Australian dollars per disability-adjusted life year (DALY), referenced to the year 2003.
Interventions that are ‘dominant’ lead to more health and less cost than if no intervention to reduce salt intake is in place.